Robust Glucose Control and Weight Loss after Six Weeks of Treatment with MEDI0382, a Balanced GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes

被引：0
|
作者：
Ambery, Philip
Stumvoll, Michael W.
Posch, Maximilian G.
Heise, Tim
Plum-Moerschel, Leona
Tsai, Lan-Feng
Robertson, Darren
Petrone, Marcella
Rondinone, Cristina
Parker, Victoria E.
Hirshberg, Boaz
Jermutus, Lutz
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1067-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Robust glucose control and weight loss after 6 weeks of treatment with MEDI0382, a balanced GLP-1/Glucagon receptor dual agonist, in patients with type 2 diabetes
    Ambery, P.
    Stumvoll, M.
    Posch, M.
    Heise, T.
    Plum-Moerschel, L.
    Tsai, L. -F.
    Robertson, D.
    Petrone, M.
    Rondinone, C.
    Parker, V.
    Hirshberg, B.
    Jermutus, L.
    DIABETOLOGIA, 2018, 61 : S362 - S362
  • [2] MEDI0382, a dual GLP-1 glucagon receptor agonist, promotes rapid glucose control and significant weight loss in patients with type 2 diabetes
    Parker, V.
    Ambery, P.
    Robertson, D.
    Posch, M.
    Plum-Moerschel, L.
    Wang, T.
    Petrone, M.
    Heise, T.
    Meier, J.
    Hirshberg, B.
    DIABETOLOGIA, 2018, 61 : S84 - S84
  • [3] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes-A Multiple-Ascending-Dose Study
    Robertson, Darren
    Stumvoll, Michael W.
    Posch, Maximilian G.
    Heise, Tim
    Plum-Moerschel, Leona
    Klein, Gernot
    Tsai, Lan-Feng
    Petrone, Marcella
    Hirshberg, Boaz
    Rondinone, Cristina
    Parker, Victoria E.
    Jermutus, Lutz
    Ambery, Philip
    DIABETES, 2018, 67
  • [4] MEDI0382, a GLP-1/glucagon receptor dual agonist, improves NASH and reduces liver fibrosis in mice
    Trevaskis, J. L.
    Boland, M. L.
    Conway, J.
    Guionaud, S.
    Grimsby, J.
    Jermutus, L.
    Rhodes, C. J.
    DIABETOLOGIA, 2018, 61 : S590 - S590
  • [5] Medi0382, a GLP-1/glucagon receptor dual agonist, reduces weight and improves metabolism via central and peripheral actions
    Baker, D.
    Oldham, S.
    Will, S.
    Church, C.
    Davies, G.
    Burke, L.
    Brown, L.
    Sulikowski, M.
    Lapointe, J. -M.
    Lewis, A.
    Jouihan, H.
    Barkholt, P.
    Gronlund, R. Veggerby
    Rhodes, C.
    Trevaskis, J.
    DIABETOLOGIA, 2018, 61 : S292 - S292
  • [6] Acute Metabolic Effects of MEDI0382, a GLP-1/Glucagon Dual Agonist, in Wild Type and GLP-1 Receptor Knockout (GLP-1RKO) Mice
    Will, Sarah E.
    Naylor, Jacqueline
    Rossi, Alessandra
    Hornigold, David
    Oldham, Stephanie
    Trevaskis, James
    Konkar, Anish
    DIABETES, 2016, 65 : A35 - A35
  • [7] Evaluating the Sub-chronic Effects of MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, on Weight Loss in Male ob/ob Mice
    Oldham, Stephanie
    Church, Christopher D.
    Will, Sarah
    Konkar, Anish
    Trevaskis, James
    Davies, Graeme R.
    DIABETES, 2018, 67
  • [8] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2019, 68
  • [9] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2018, 67
  • [10] MEDI0382, a GLP/Glucagon Receptor Dual Agonist, Significantly Reduces Hepatic Fat Content in Subjects with Type 2 Diabetes Mellitus
    Jain, Meena
    Tsai, Lan-Feng
    Robertson, Darren
    Hirshberg, Boaz
    Hockings, Paul
    Johansson, Lars
    Ambery, Philip
    DIABETES, 2018, 67
12345